Taiho Oncology

Taiho Oncology, Inc. is a pharmaceutical company specializing in the development and commercialization of innovative cancer treatments. They generate revenue through the sale of proprietary oncology drugs and therapies, focusing on improving patient outcomes. Founded as a subsidiary of Taiho Pharmaceutical Co., Ltd., the company has a strong history of research and development, with several key products approved by regulatory authorities worldwide. Their commitment to advancing cancer care is reflected in their robust pipeline of clinical trials and strategic partnerships.

Recent Posts by Taiho Oncology

1-20 of 143